Question 1

What safeguards protect household privacy in big-data linkages?

Accepted Answer

Protecting household privacy in big-data linkages relies on techniques that anonymize and secure personal information during data merging. One key safeguard is de-identification: before datasets are linked, direct identifiers (names, exact addresses, etc.) are removed or replaced with codes so individual households aren't directly exposed. Privacy-preserving record linkage methods can also be used-techniques like hashing or encrypting identifiers allow matching records between datasets without revealing personal identities. After linking, results are often aggregated so analysts see trends at a group level rather than details about any single household. Strict data use agreements and access controls add another layer of protection: only authorized analysts can access the linked data, and they are legally bound not to attempt re-identification. Some organizations even apply differential privacy (adding a bit of statistical noise to results) when sharing insights, ensuring no individual family can be pinpointed. All these safeguards let researchers gain insights from combined data while keeping families' information safe.

Question 2

Will category entry points reshape how we model mental availability?

Accepted Answer

Yes — incorporating category entry points (the situational cues that prompt brand recall) is reshaping how mental availability is modeled by adding context to brand salience. Traditionally, mental availability was measured broadly (how easily a brand comes to mind), but now marketers map specific occasions or triggers when consumers think of the brand. For example, instead of just tracking general awareness, a coffee brand might quantify how often it's top-of-mind for "morning commute" vs. "afternoon pick-me-up." By modeling these distinct category entry points, brands get a granular view of where and when they hold memory real estate. This approach refines mental availability models: success is not only being known in general, but being salient in the key situations that drive purchase decisions. Ultimately, brands are focusing on owning relevant entry points to enhance their overall mental availability.

Question 3

How can I prove ROI from advanced analytics to non-technical executives?

Accepted Answer

To prove ROI from advanced analytics to non-technical executives, translate the results into clear business outcomes and financial gains that align with their priorities. Rather than focusing on the technical details, show how analytics made a measurable impact — for example, a predictive model that reduced customer churn by 10% or an AI-driven process that cut operating costs by $500,000. Use plain language and concrete case studies: e.g., "After implementing advanced analytics, our marketing campaign yielded X more leads, translating to Y in additional revenue." Visual aids like before-and-after charts can highlight the trend improvements without jargon. The key is directly linking analytics projects to metrics executives care about (revenue, cost savings, risk reduction) and backing it with evidence from pilots or benchmarks. When they see a dollar value or KPI lift tied to analytics, the ROI becomes tangible for a non-technical audience.

Question 4

Can AI simulate consumer reactions to new product concepts reliably?

Accepted Answer

AI (artificial intelligence) can approximate consumer reactions to new product ideas with increasing sophistication, but it's not yet a perfect stand-in for real consumer feedback. Advanced predictive models and large language models can be trained on massive datasets of past consumer responses, allowing them to simulate whether a concept might be liked or criticized. This can give quick, early insight into likely reactions and flag obvious issues before investing in market tests. For instance, some companies use AI to run virtual 'focus groups' that predict which aspects of a concept might draw praise or criticism within minutes. It's a useful early filter, but not a final verdict — if an idea is truly novel or emotionally charged, there's still no substitute for testing it with real consumers, since AI predictions only go as far as patterns it's seen before.

Question 5

How is pressure on drug pricing affecting pharma market research priorities?

Accepted Answer

Under intense scrutiny to justify drug costs, pharmaceutical companies are refocusing their market research efforts on demonstrating value and understanding pricing perceptions. For instance, there's a surge in health economics and outcomes research studies that quantify a drug's real-world benefits relative to its price, helping to show payers and regulators that a treatment is worth the cost. Market research is also increasingly probing the perspectives of insurers and healthcare providers on pricing: companies want to know how cost concerns affect formulary placement, prescribing decisions, or therapy adoption. At the same time, patient-centric research has gained priority - exploring issues like whether high co-pays are causing patients to skip doses, how sensitive different patient groups are to price changes, and what messaging about value resonates with the public. In short, as pricing pressure grows, pharma market research is pivoting toward uncovering insights that can support pricing strategy, value communication, and access negotiations.

RESEARCH STRATEGY GROUP INC.

Why choose Us

What is RESEARCH STRATEGY GROUP INC.?

Services and Expertise

Published on Greenbook

Sports Betting – Researching the Revolution

Client Projects and Success Stories

Market Research FAQs with Expert Insights

What safeguards protect household privacy in big-data linkages?

Will category entry points reshape how we model mental availability?

How can I prove ROI from advanced analytics to non-technical executives?

Can AI simulate consumer reactions to new product concepts reliably?

How is pressure on drug pricing affecting pharma market research priorities?